EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Risk of new‐onset and prevalent disease in chronic rhinosinusitis: A prospective cohort study

Annemarie G Hirsch iD, Brian S Schwartz, Cara Nordberg, Bruce K Tan, Robert P Schleimer, Robert C Kern, Anju T Peters, Karen Bandeen-Roche, Ashton E Lehmann

International Forum of Allergy & Rhinology · 2023

DOI: 10.1002/alr.23136 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Forum of Allergy & Rhinology, 2023. Verfasst von Annemarie G Hirsch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, Geisinger, Danville, Pennsylvania, USA. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Pulmonary Disease, Chronic Obstructive, Asthma, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic rhinosinusitis (CRS) is accompanied by burdensome comorbid conditions. Understanding the relative timing of the onset of these conditions could inform disease prevention, detection, and management.

Objective

To evaluate the association between CRS and new‐onset and prevalent asthma, noncystic fibrosis bronchiectasis (NCFBE), chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease (GERD), and obstructive sleep apnea (OSA).

Methods

We conducted a prospective cohort study among primary care patients using a detailed medical and symptom questionnaire in 2014 and again in 2020. We used questionnaire and electronic health record (EHR) data to determine CRS status: CRS SE (moderate to severe symptoms with EHR evidence), CRS E (limited symptoms with EHR evidence), CRS S (moderate to severe symptoms without EHR evidence), CRS neg (limited symptoms and no EHR evidence; reference). We evaluated the association between CRS status and new‐onset and prevalent disease using logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs).

Results

There were 7847 and 4445 respondents to the 2014 and 2020 questionnaires, respectively. CRS SE (vs CRS neg ) was associated with increased odds of new‐onset asthma (OR, 1.74 [CI, 1.09–2.77), NCFBE (OR, 1.87 [CI, 1.12–3.13]), COPD (OR, 1.73 [CI, 1.14–2.68]), GERD (OR, 1.95 [CI, 1.61–2.35]), and OSA (OR, 1.91 [CI, 1.39–2.62]). Similarly, increased odds were observed for associations with the prevalence of these conditions.

Conclusion

The findings from the study support further exploration of CRS as a target for the prevention and detection of asthma, NCFBE, COPD, GERD, and OSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxPulmonary Disease, Chronic ObstructiveAsthmaSleep Apnea, ObstructiveBronchiectasisSinusitisHumansProspective StudiesChronic Disease

Stichwörter der Autor:innen

asthmabronchiectasischronic obstructive pulmonary diseasechronic rhinosinusitisgastroesophageal reflux diseaseobstructive sleep apnea

Autor:innen und Institutionen

  • Department of Population Health Sciences, Geisinger, Danville, Pennsylvania, USA.
  • Department of Environmental Health and Engineering, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Otolaryngology Head and Neck Surgery, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Otolaryngology/Head and Neck/Facial Plastic Surgery, Geisinger Health System, Danville, Pennsylvania, USA.

ORCID-Profile: Annemarie G Hirsch

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Hirsch, A. G., Schwartz, B. S., Nordberg, C., Tan, B. K., Schleimer, R. P., Kern, R. C., Peters, A. T., Bandeen-Roche, K., & Lehmann, A. E. (2023). Risk of new‐onset and prevalent disease in chronic rhinosinusitis: A prospective cohort study. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23136

Vancouver

Hirsch AG, Schwartz BS, Nordberg C, Tan BK, Schleimer RP, Kern RC, et al. Risk of new‐onset and prevalent disease in chronic rhinosinusitis: A prospective cohort study. International Forum of Allergy & Rhinology. 2023. doi:10.1002/alr.23136

BibTeX
@article{Hirsch2023,
  author = {Hirsch, Annemarie G and Schwartz, Brian S and Nordberg, Cara and Tan, Bruce K and Schleimer, Robert P and Kern, Robert C and Peters, Anju T and Bandeen-Roche, Karen and Lehmann, Ashton E},
  title = {Risk of new‐onset and prevalent disease in chronic rhinosinusitis: A prospective cohort study},
  journal = {International Forum of Allergy & Rhinology},
  year = {2023},
  doi = {10.1002/alr.23136}
}
Kostenlos starten →